Purple Biotech Ltd. (NASDAQ: PPBT)
$0.38
+0.0038 ( +1.00% ) 109.1K
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
Market Data
Open
$0.38
Previous close
$0.38
Volume
109.1K
Market cap
$12.84M
Day range
$0.37 - $0.40
52 week range
$0.30 - $1.80
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 2 | Jul 02, 2024 |
| 6-k | Quarterly Reports | 6 | Jul 02, 2024 |
| 6-k | Quarterly Reports | 2 | Jul 01, 2024 |
| 6-k | Quarterly Reports | 3 | Jun 27, 2024 |
| 6-k | Quarterly Reports | 6 | Jun 26, 2024 |
| 6-k | Quarterly Reports | 1 | Jun 20, 2024 |
| 6-k | Quarterly Reports | 54 | Jun 04, 2024 |
| 6-k | Quarterly Reports | 3 | Jun 03, 2024 |
| 6-k | Quarterly Reports | 2 | May 21, 2024 |
| 6-k | Quarterly Reports | 46 | May 02, 2024 |